Submitted:
16 November 2026
Posted:
17 November 2026
You are already at the latest version
Abstract
Background: Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome caused by impaired liver function. HE patients suffer from learning and memory dis-turbances, as well as altered motor activity, and anxiety among others. There is currently no fully reliable and standardized animal model that faithfully recapitulates the com-plexity of type C HE, and effective pharmacological therapies remain limited. Methods: The present investigation aimed to assess locomotor behavior and memory function in a mouse model of chronic HE induced by thioacetamide (TAA) administration (TAA 200mg /Kg BW i.p) in mice along with the possible neuroprotective and hepatoprotective effects of hesperidin (HEN). Memory function was assessed by Y-maze and novel object recognition tests, while we used Rotarod to assess motor coordination and open field test for motor function. Results: Our findings showed that TAA-treated mice exhibited sig-nificant hepatic and extrahepatic alterations evidenced by altered liver and renal markers as well as increased liver size and kidney morphometry. Our TAA-treated mice exhibited an obvious decline of short-term spatial working memory and altered loco-motor behavior. While HEN administration (200mg/Kg BW by oral gavage) for 7 days improved hepatic and renal function, and restored memory performance and locomotor behavior in TAA-treated mice. Computational analyses, including molecular docking and pharmacokinetic predictions, revealed that HEN binds effectively to key targets; MAO-A, AChE, and Keap1 suggesting its potential role in modulating monoaminergic and cholinergic systems. Conclusions: These findings support HEN as a multi-target agent with therapeutic potential, though further development is needed to address pharmacokinetic limitations.
Keywords:
hepatic encephalopathy
; locomotor behavior
; memory
; hesperidin
; molecular docking
; pharmacokinetic predictions
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.